Photo provided by IAEC Source: Hemophilia Life
Hello. This is LACELLIC. LACELLIC has signed a strategic business agreement (MOU) with cancer treatment operations and medical concierge company IAEC. This agreement was promoted to link the expertise and medical networks of both companies in the fields of international cancer treatment and regenerative medicine for incurable diseases, and to expand treatment linkages and medical service cooperation with domestic and foreign medical institutions.
The agreement ceremony held at LACELLIC headquarters in Seoul on August 13, 2026 was attended by key officials, including IAEC CEO Lee Hyo-bin and LACELLIC Chairman Seon Jun-min.
Cooperation connecting international cancer treatment and regenerative medicine IAEC supports related medical services based on management and operation technology related to the operation of heavy ion accelerator cancer treatment equipment, and has recently been expanding its medical concierge business in connection with overseas medical institutions.
We operate a full-cycle support system, from preparing medical data for patients considering overseas treatment, to guiding them through the treatment process, to linking them with domestic tests and progress observations after returning to their home country.
LACELLIC is a platform company that is building a medical infrastructure and global network centered on international cancer treatment and cutting-edge regenerative medicine for incurable diseases. Through this agreement, we plan to provide more diverse treatment information by linking IAEC's cancer treatment-related operational experience with LACELLIC's regenerative medicine platform and cooperate to help patients review various treatment options.
Operation of the IAEC International Medical Center within the Seoul LACELLIC Clinic Currently, the IAEC International Medical Center is operated within the Seoul LACELLIC Clinic. Through this, a variety of support is provided, such as preparing medical data for patients considering treatment at overseas medical institutions, checking whether they are adaptable to treatment, and connecting them with domestic medical institutions.
Future Cooperation Directions The two companies plan to expand treatment-linked services targeting domestic and foreign medical institutions and continue cooperation to provide various treatment options to patients with cancer and incurable diseases.
In addition, we plan to expand the scope of cooperation to various fields such as joint marketing and research and development, and strengthen links in the global medical service market.
LACELLIC will continue to expand cooperation with domestic and foreign medical institutions and specialized companies, focusing on regenerative medicine, and continue to build a wider range of medical services and a global network.
Hemophilia Life “IAEC signs strategic business agreement with LACELLIC… “International Cooperation in Cancer Treatment and Regenerative Medicine for Incurable Diseases” ※ This post was reconstructed based on published media reports.
Inquiry +82 10-7667-6057
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul
